Archive—Events 2022

2022 Seminars and Events
 

November 1, 2022

Understanding Cannabis and Tobacco Co-Use: Health Equity Perspective

12:00-12:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Dr. LaTrice Montgomery, PhD (she/her), is a Research Associate Professor and Licensed Clinical Psychologist in the Center for Addiction Research/Addiction Sciences Division of the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine. She received her Ph.D. in Clinical Psychology from the University of Cincinnati and completed her internship in the Division of Substance Abuse at the Yale University School of Medicine. Her research focuses on cannabis and tobacco use and co-use, medical cannabis and racial disparities in the prevention and treatment of substance use disorders. She currently has a career development award (K23) from the National Institute on Drug Abuse to develop and pilot test a Twitter-based intervention designed to promote cannabis use reduction among young adults who frequently smoke blunts. Dr. Montgomery also has a pilot grant from UC to conduct a mixed methods study on the health and social effects of medical cannabis. Dr. Montgomery is a standing member for the NIH Interventions to Prevent and Treat Addictions Study Section and the VA Career Development Panel. She is an Associate Editor and Social Media Editor for the Journal of Substance Abuse Treatment, and an Associate Editor for Cannabis.

Summary

• Describe prevalence and modes of cannabis and tobacco use and co-use
• Describe health inequities associated with cannabis and tobacco co-use
• Discuss ideas for future cannabis and tobacco co-use research, with a special emphasis on eliminating health disparities

October 17 & 31, 2022

The lifecycle of a health-equity informed qualitative project

See seminar times below

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

The Qualitative Research Program is excited to announce an upcoming hands-on workshop focused on the lifecycle of a health-equity informed qualitative project, flowing from conception through to dissemination. This virtual workshop will be held on these days and times:

• Monday October 17
  • Session 1 8:30-9:45 AM PT Foundational Principles
  • Session 2 10:00-11:15 AM PT Data Collection and Fieldwork

• Monday October 31
  • Session 3 8:30-9:45 AM PT Qualitative Data Analysis
  • Session 4 10:00-11:15 AM PT Presenting Qualitative Work to Diverse Audiences

The sessions build on each other and content will not repeat, but they are designed to stand alone, so please come even if you can only attend one or two.

September 19, 2022

Improving Representation in Clinical Trials and Research: an overview of the NASEM report for Kaiser Permanente Washington Health Research Institute

4:00-4:55pm

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Gloria Coronado, PhD, is an epidemiologist and the Mitch Greenlick Endowed Distinguished Investigator in Health Disparities Research at Kaiser Permanente Center for Health Research. She completed her training at Stanford University (BA 1994, Psychology) and the University of Washington (MS 1998, PhD 2001, Epidemiology). Through her practice-based research, Dr. Coronado champions affordable, long-term solutions to health disparities issues. She leads a well-funded portfolio of research that inspires health system leaders to make sensible, evidence-informed choices to successfully engage hard-to-reach populations in life-saving preventive behaviors. Dr. Coronado has developed several innovative and cost-effective interventions to improve rates of participation in cancer screening among patients served by community health centers. Her innovative work has led to successful partnerships with large health plans, state institutions, and community clinics. She currently directs or co-directs three programs that use systems-based approaches to raise the rates of colorectal cancer screening and follow-up care in health plans and clinics in Washington, Oregon and California. Over the course of her career, Dr. Coronado has served as a PI or co-I on over 35 federally funded grants; she has co-authored over 200 peer-reviewed manuscripts. She served as a committee member of the National Academies of Sciences, Engineering, and Medicine on Improving the Representation of Women and Underrepresented Minorities in Clinical Trials and Research. She is currently a member of the Board of Scientific Advisors for the National Cancer Institute.

Summary

In May of this year, the National Academies of Sciences, Engineering, and Medicine released a report that provided the most comprehensive examination to date of the representation of women and underrepresented populations in clinical trials in research. This new report makes a compelling case for why we need more equitable participation in clinical trials and clinical research, including an economic analysis on the cost of health disparities in the United States. It provides a review of the barriers to having more equitable participation in clinical trials, describes strategies to overcome those barriers, and provides actionable recommendations to drive lasting change on this issue.

Please join the National Academies and members of the report committee to discuss their recent report, Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. During this webinar, members of the committee that developed the report will provide a detailed overview of the report and will discuss its conclusions and recommendations, followed by a moderated question and answer period with the audience.

September 6, 2022

Linking Data on Modern Older Americans to Early 20th Century U.S. Decennial Census Data

12:00-12:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: John Robert ("Rob") Warren (he/him/his), Professor, Minnesota Population Center, University of Minnesota. I am a sociologist, demographer, education scholar, and population health scientist. Among other things, I produce data useful for studying the long-term consequences of childhood experiences, exposures, and conditions for later-life cognitive, health, and mortality outcomes. In this line of work, I (a) co-lead two cohort studies that have followed nationally representative samples of Americans from high school through late adulthood and (b) have spent the last several years linking records from modern surveys of older people to U.S. Census data front he early 20th century when those people were observed as children living in their families, households, and communities.

Summary

Modern data on older Americans facilitate a wide range of research on cognitive, morbidity, mortality, financial, and other outcomes in late life. However, most cohort and administrative data on older Americans contains only sparse information about people's early life experiences, exposures, and conditions; the information that is available is often gathered retrospectively and with associated loss of precision and detail. In this talk I will describe recent efforts to link several cohort studies of older people to early 20th-century decennial U.S. Census data; demonstrate the kinds of research made possible by such linkages; and discuss the prospect of linking the ACT study to census records.

July 19, 2022

InvesT1D: Improving adolescent diabetes health at what cost?

4:00-4:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Davene R. Wright, PhD is a health care researcher who uses decision sciences methodologies to design patient-centered interventions and to promote policies that can improve the management of pediatric chronic diseases. Dr. Wright is based in the Department of Population Medicine, a research and academic partnership between the Harvard Pilgrim Health Care Institute and Harvard Medical School. There, she is part of the Center for Healthcare Research in Pediatrics and the Division of Chronic Disease Across the Lifecourse and she is on faculty in the Harvard PhD Program in Health Policy. Until 2019, Dr. Wright was an Assistant Professor in the University of Washington Departments of Pediatrics and Pharmacy. Dr. Wright received a BS in Polymer and Textile Chemistry from the Georgia Institute of Technology where she was a President’s Scholar and ORISE Fellow. She earned her PhD in Health Policy and Decision Sciences from Harvard University in 2012 where she was a recipient of the National Science Foundation Graduate Research Fellowship. She is a Trustee for the Society for Medical Decision Making (SMDM), co-chair of the SMDM 2022 North American annual meeting in Seattle, and co-chair of the Decision Sciences for Child Health Collaborative.  In her work, she utilizes conjoint analysis, economic evaluation, simulation modeling, health services research, and behavioral economic research methods. Dr. Wright’s work has been funded by NIH, the American Heart Association, and the American Diabetes Association. You can find her on Twitter @WrightCensored

Summary

By providing individuals with immediate, consistent inducements for tasks which do not provide proximal tangible benefits, financial incentives can improve short-term adherence to health behaviors. However, most financial incentive studies are not flexible, patient-centered, sustainable, and incentive payments lack an empirical basis. Using qualitative interviews with families, an ethical analysis, and a discrete choice experiment, we developed the InvesT1D intervention, which aims to improve adolescent adherence to type 1 diabetes management goals. In this talk, we will present our developmental research approach, results from our pilot randomized controlled trial, and we will discuss potential challenges to implementing such an intervention in the real-world.

June 27, 2022

Health Equity and Qualitative Research: Elijah Anderson

12:00-12:55 PM

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

The Qualitative Research Program is very excited to announce that Professor Elijah Anderson will be kicking off our speaker series on health equity and qualitative research!

The Sterling Professor of Sociology and of African American Studies at Yale University, and one of the leading sociologists and urban ethnographers in the United States, Dr. Anderson is the author of a great number of books, including Black in White Space: The Enduring Impact of Color in Everyday Life (2022), Code of the Street: Decency, Violence, and the Moral Life of the Inner City (1999), and Streetwise: Race, Class, and Change in an Urban Community (1990), as well as dozens of articles and book chapters. The significance of his scholarship on race, inequality, criminal justice, and urban America has been recognized through numerous prestigious awards, including the 2017 Merit Award from the Eastern Sociological Society, the 2018 W.E.B. DuBois Career of Distinguished Scholarship Award, the 2021 Robert and Helen Lynd Award for Lifetime Achievement, and the 2021 Stockholm Prize in Criminology.

June 21, 2022

Estimated National Prescription Drug Savings from Applying Value-Based Prices

4:00-4:30pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Kai Yeung, PharmD, PhD, is a pharmacist and pharmaceutical economist with expertise in patient medication-use behaviors, insurance design, and outcomes research. His objective is to develop and evaluate incentives to encourage high-value use of health care services. Dr. Yeung has conducted research evaluating policies focused on specialty drug access, value-based insurance design, the consequences of insurance switching, and financial incentives. He combines applied econometric and cost-effectiveness analysis tools with a clinical understanding of prescription drugs and health insurance design to gain new insights in these areas.

Summary

This presentation will address the question, “How would national drug spending change from applying value-based pricing?”

June 7, 2022

Guidelines for Artificial Intelligence in Medicine: A review and content analysis

12:00-12:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Norah Crossnohere, PhD, is a Research Scientist at The Ohio State University College of Medicine, Department of Biomedical Informatics. She is a social scientist whose research applies and advances mixed-methods approaches to measure patient experiences and preferences. She has experience in the use of choice experiments, patient engagement methods, and patient-reported outcome measures to inform medical decision-making across the translational spectrum. She has applied these methods in cancer, pediatric conditions, and rare diseases, as well as to inform patient-centered use of health information technologies.

Summary

Artificial intelligence (AI) is rapidly expanding in medicine even while lacking formal oversight or guidance. We sought to explore the content of published frameworks describing best practices for the use of AI in medicine. We identified thirteen frameworks reporting on general guidelines or reporting practices for the use of AI in medicine. Content analysis of the frameworks revealed five overarching considerations related to the oversight of AI in medicine, including: transparency, reproducibility, ethics, effectiveness, and engagement. Frameworks provided broad guidance for the oversight of AI in medicine, but notably offered less input on the role engagement approaches for oversight, and regarding the translational stage of surveillance. Identifying and optimizing strategies for engagement is essential to ensure that AI can meaningfully benefit patients and other end-users.

February 1, 2022

Value-Based Payment: Impact on Outcomes and Equity

12:00-12:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Joshua M. Liao, MD, MSc, FACP (he/him), is a board-certified internal medicine physician and faculty in the UW Schools of Medicine and Public Health, where he is also the Associate Chair for Health Systems in the Department of Medicine and the Medical Director of Payment Strategy at UW Medicine. He is also an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania.

Dr. Liao's scholarship focuses on how systems of financing and delivering care work together with human behavior to affect health outcomes. Equity in payment and care delivery redesign is a key focus of this portfolio, which spans multiple federally funded grants, policymaker collaborations, and advocacy work. His payment expertise includes service on the US Department of Health and Human Services' Physician-Focused Payment Model Technical Advisory Committee (PTAC), as well as an advisor to the American Medical Association's RVU Update Committee (RUC).

Summary

Review of Dr. Liao’s research evaluating the association between payment models. Such as bundled payments and ACOs on patient outcomes and health disparities. Articulate areas of needed future work in payment and policy research.

January 18, 2022

Adolescent Depression and Suicidality: Rethinking Intervention

4:00-4:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Elizabeth McCauley, PhD, ABPP, (she/her). Clinically I serve as an Attending on the Psychiatry/Psychology CL service at SCH and a provider in the Crisis Care Clinic (CCC). The CCC is a new program we have developed specifically to address needs of suicidal youth and their families.  We are currently beginning a NIMH trial to study the efficacy of our CCC model of care as well as the Suicide Prevention Intervention- developed by Barbara Stanley and Greg Brown. My motivation to do this work in informed by a concern that in the face of suicidality our mental health system has been overly reliant on ED evaluations and inpatient hospitalizations that increase focus on medicalization of what for many youths are more transient issues related to poor emotion regulation skills in the face of environmental stressors.

Summary

• Summarize current findings on the efficacy of psychotherapeutic interventions in addressing suicidality among youth.
• Discuss strategies to improve treatment approaches and outcomes that are more equitable by moving away from over medicalizing mental health crises and expanding access to care.

   Find Us

Map and directions to KPWHRI